Trials / Completed
CompletedNCT02217943
Prospective Metabolic Surgery in T2DM Chinese Subjects
A Prospective, Multi-Center Study for the Evaluation of Metabolic Surgery in Subjects With Type 2 Diabetes in China
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Ethicon Endo-Surgery · Industry
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The primary goal of this study is to assess impact of metabolic surgery on glycemic control in diabetic patients.
Detailed description
The primary objective of this study is to assess the impact of metabolic surgery (Roux-en-Y gastric bypass \[RYGB\] or sleeve gastrectomy \[SG\]) on composite measure of glycemic control at 2 years post surgery in a Type 2 Diabetes Mellitus (T2DM) cohort of subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Roux-en-Y gastric bypass | |
| PROCEDURE | Sleeve gastrectomy |
Timeline
- Start date
- 2014-07-31
- Primary completion
- 2018-06-05
- Completion
- 2021-04-11
- First posted
- 2014-08-15
- Last updated
- 2025-03-30
Locations
6 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02217943. Inclusion in this directory is not an endorsement.